SMALES KELLY sold 0.6% of their position (475.00 shares) of TRANSPHORM, INC. on the open market
Open‑market sale worth $2.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/26/2024ACC: 0001415889-24-011577
-475.00
Net shares
Net seller
$2.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
475.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−475.00
Price / share
$4.85
Trade value
$2.30K
% of position
0.6%
4/24/2024
74.15K→73.67K
Total
Net shares
−475.00
Net value
-$2.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/24/2024 | S · Sale | −475.00 | $4.85 | $2.30K | 0.6% | 74.15K | 73.67K |
| Total | −475.00 | -$2.30K | ||||||
Derivative Transactions0
No derivative transactions reported